Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 634,800 shares, a decrease of 11.3% from the June 30th total of 715,700 shares. Based on an average daily volume of 2,520,000 shares, the short-interest ratio is presently 0.3 days. Currently, 7.0% of the company’s stock are sold short.
An institutional investor recently raised its position in Aethlon Medical stock. Morgan Stanley grew its stake in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) by 9,823.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 69,268 shares of the medical equipment provider’s stock after purchasing an additional 68,570 shares during the period. Morgan Stanley owned approximately 0.74% of Aethlon Medical worth $106,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 3.07% of the company’s stock.
Shares of NASDAQ AEMD opened at $1.94 on Friday. The firm’s 50-day moving average price is $1.98 and its 200-day moving average price is $1.91. Aethlon Medical has a 1-year low of $0.76 and a 1-year high of $6.89.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.
Featured Story: What is meant by buying and selling pressure?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.